CHARLES RIVER LABORATORIES INTERNATIONAL, INC.·4

Mar 4, 4:13 PM ET

Smith David Ross 4

4 · CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Filed Mar 4, 2022

Insider Transaction Report

Form 4
Period: 2022-03-03
Smith David Ross
Corporate Executive VP & CFO
Transactions
  • Exercise/Conversion

    Common Stock

    2022-03-03$144.67/sh+3,304$477,99032,969 total
  • Sale

    Common Stock

    2022-03-03$285.16/sh387$110,35725,819 total
  • Exercise/Conversion

    Stock Options (Right to Buy)

    2022-03-033,8460 total
    Exercise: $109.34From: 2019-02-23Exp: 2023-02-23Common Stock (3,846 underlying)
  • Exercise/Conversion

    Stock Options (Right to Buy)

    2022-03-033,3043,305 total
    Exercise: $144.67From: 2020-02-22Exp: 2024-02-22Common Stock (3,304 underlying)
  • Exercise/Conversion

    Stock Options (Right to Buy)

    2022-03-031,8155,446 total
    Exercise: $179.66From: 2021-05-29Exp: 2030-05-29Common Stock (1,815 underlying)
  • Exercise/Conversion

    Common Stock

    2022-03-03$109.34/sh+3,846$420,52229,665 total
  • Exercise/Conversion

    Common Stock

    2022-03-03$179.66/sh+1,815$326,08334,784 total
  • Sale

    Common Stock

    2022-03-03$281.49/sh3,825$1,076,71630,959 total
  • Sale

    Common Stock

    2022-03-03$282.56/sh2,606$736,36128,353 total
  • Sale

    Common Stock

    2022-03-03$283.41/sh1,289$365,31627,064 total
  • Sale

    Common Stock

    2022-03-03$284.58/sh858$244,17126,206 total
Footnotes (5)
  • [F1]This transaction was executed in multiple trades at prices ranging from $280.98 to $281.93. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F2]This transaction was executed in multiple trades at prices ranging from $281.98 to $282.93. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F3]This transaction was executed in multiple trades at prices ranging from $283.00 to $283.7. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F4]This transaction was executed in multiple trades at prices ranging from $284.28 to $284.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F5]This transaction was executed in multiple trades at prices ranging from $285.09 to $285.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT